Cinacalcet Tablet, Film Coated
Product Images NDC 63629-9608

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 63629-9608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cinacalcet-fig3 (Cinacalcet Fig3)

A line graph depicting calcium levels (mg/dL) over weeks for patients with parathyroid carcinoma undergoing titration and maintenance phases of treatment. The x-axis represents time in weeks, and the y-axis shows serum calcium concentration with error bars illustrating variability at each time point.*

FDA Label Image

Cinacalcet-fig4.jpg (Cinacalcet Fig4)

A line graph depicting calcium levels (mg/dL) over time in weeks for a study involving patients with intractable pHPT. The x-axis represents weeks from baseline through titration to maintenance phases, while the y-axis shows calcium concentration. Data points include error bars indicating variability at each time point.*

FDA Label Image

Cinacalcet-figure-1.jpg (Cinacalcet Figure 1)

A line graph titled 'Mean (SE) iPTH Values (Pooled Phase 3 Studies)' showing iPTH levels (pg/mL) over 26 weeks. The graph compares two groups: placebo and Cinacalcet. Cinacalcet shows a downward trend in iPTH levels over time, whereas the placebo group remains relatively stable. The x-axis is marked in weeks, and the y-axis measures iPTH levels.*

FDA Label Image

Cinacalcet-figure-2 (Cinacalcet Figure 2)

A line graph titled 'Mean (SE) Ca x P Values (Pooled Phase 3 Studies)' comparing calcium-phosphorus product levels over 26 weeks. Two lines represent Cinacalcet and placebo group values, with Ca x P measured in mg/dL squared on the y-axis and weeks on the x-axis. Cinacalcet group values decrease over time, while placebo values remain relatively steady.*

FDA Label Image

Cinacalcet-str (Cinacalcet Str)

Chemical structure of cinacalcet hydrochloride, showing the molecular arrangement including a trifluoromethyl group, aromatic rings, and an amine group associated with hydrochloride.*

FDA Label Image

Label (Lbl636299608)

Cinacalcet Tablets 30 mg film-coated oral tablets packaging label shows the product name, strength, and quantity of 30 tablets. The label includes storage instructions, barcode, NDC 63629-9608-1, and is relabeled by Bryant Ranch Prepack, Inc., Burbank, CA. The label features the BRP Pharmaceuticals logo and indicates the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.